Vericel Corp.
(NASDAQ : ASTM)

( )
ASTM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 2.21%416.231.0%$504.54m
DHRDanaher Corp. 3.00%206.000.7%$482.10m
ISRGIntuitive Surgical, Inc. 1.20%683.092.4%$454.50m
ABTAbbott Laboratories 1.62%100.660.8%$454.05m
MDTMedtronic Plc 1.35%102.080.6%$450.16m
DXCMDexCom, Inc. 4.07%427.898.3%$366.42m
BDXBecton, Dickinson & Co. 0.82%257.101.0%$330.21m
BSXBoston Scientific Corp. 1.68%39.971.0%$313.26m
INOInovio Pharmaceuticals, Inc. -5.95%13.755.9%$304.55m
VARVarian Medical Systems, Inc. 0.11%173.489.1%$298.85m
BAXBaxter International, Inc. 0.66%83.491.8%$272.99m
ALGNAlign Technology, Inc. 1.27%307.986.4%$268.02m
SYKStryker Corp. 0.62%190.091.3%$252.42m
EWEdwards Lifesciences Corp. 2.53%78.600.4%$206.68m
QDELQuidel Corp. 4.36%239.597.7%$194.89m

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.